G. W. Cance, J. E. Harris, M. V. Iacocca, E. Roche, X. H. Yang, J. Chang, S. Simkins and L. X, “Immunohistochemical Analyses of Focal Adhesion Kinase Expression in Benign and Malignant Human Breast and Colon Tissues: Correlation with Preinvasive and Invasive Phenotypes,” Clinical Cancer Research, Vol. 6, 2000, pp. 2417-2423.

has been cited by the following article:

• TITLE: Studies on Focal Adhesion Kinase in Human Breast Cancer Tissue

  AUTHORS: Kirat Kumar Ganguly, Triparna Sen, Syamsundar Mandal, Jaydip Biswas, Amitava Chatterjee

  KEYWORDS: FAK; Human Breast Cancer

  JOURNAL NAME: Journal of Cancer Therapy, Vol.3 No.1, February 16, 2012

  ABSTRACT: Aim: To study Expression and Phosphorylation status of Focal Adhesion Kinase (FAK) in Human Breast Cancer tissue. To study the relation of FAK with standard clinicopathological parameters of Human Breast Cancer. Methods: Tissue collection, Protein extraction, RNA isolation, Western Blot, Immunohistochemistry, RT-PCR, ELISA, Statistical analysis. Results: All the four techniques showed upregulated expression, phosphorylation (Tyr-397) and processing of FAK in human breast cancer tissue compared to the adjacent non-tumor tissue of the same patient. Upregulation of FAK was found to be increased parallely with the advancement of cancer. Localisation of FAK was found to be membrano-cytoplasmic. FAK is upregulated both in protein and mRNA level. Expression and phosphorylation of FAK is increased specifically in the tumor regions compared to the surrounding non-tumor region. Upregulation of FAK was frequently found in ER-positive and PR-positive but Her2/neunegative breast cancer cases. Conclusion: FAK has crucial role in development and progression of human breast cancer. FAK may be considered as an indicator of human breast cancer progression. FAK processing may be considered as an indicator of invasive potential of breast cancer. FAK may be considered as a clinical indicator of human breast cancer development and progression.